Targeting the Glutamatergic System to Treat Pathological Gambling: Current Evidence and Future Perspectives

Pathological gambling or gambling disorder has been defined by the DSM-5 as a behavioral addiction. To date, its pathophysiology is not completely understood and there is no FDA-approved treatment for gambling disorders. Glutamate is the principal excitatory neurotransmitter in the nervous system an...

Descripción completa

Detalles Bibliográficos
Autores principales: Pettorruso, Mauro, De Risio, Luisa, Martinotti, Giovanni, Di Nicola, Marco, Ruggeri, Filippo, Conte, Gianluigi, Di Giannantonio, Massimo, Janiri, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075088/
https://www.ncbi.nlm.nih.gov/pubmed/25013755
http://dx.doi.org/10.1155/2014/109786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075088/
https://www.ncbi.nlm.nih.gov/pubmed/25013755
http://dx.doi.org/10.1155/2014/109786

Ejemplares similares